It is essential that patients inform their healthcare provider about all medications, including tirzepatide
Not only are we stressed, anxious and overwhelmed, but were downright exhausted
Key supporting research from 2024-2025 includes a July 2024 paper in Inflammopharmacology (PMID: 38980576) linking BPC-157 to stress response mechanisms, a January 2025 HSS Journal systematic review on neuromuscular applications (PMID: 40756949), and a 2025 Journal of Neuropsychiatry and Clinical Neurosciences perspectives paper positioning BPC-157 as an emerging therapeutic for CNS disorders
Our philosophy is simple: You shouldnt have to take a gamble on your research
Works well, arrives in a timely manner, feeling good
Individuals with active cancer, recent cancer history, or strong family history of aggressive cancers should avoid BPC-157 as a precautionary measure